Tags

Type your tag names separated by a space and hit enter

Inhaled platelet-activating factor increases airway sensitivity but not maximal airway narrowing to methacholine in normal subjects.
Monaldi Arch Chest Dis. 1994 Sep; 49(4):288-92.MA

Abstract

To examine the effect of inhaled platelet-activating factor (PAF) on airway sensitivity and on maximal airway narrowing, we measured airway response to doubling concentrations of methacholine (MCh) 48 h before and 48 h after inhalation of 10, 50 and 100 micrograms of PAF in six nonatopic, nonasthmatic subjects. The forced expiratory volume in one second (FEV1) and airflow at 30 percent of vital capacity (V30) from partial forced expiration were used to assess changes in airway calibre. Inhalation of PAF caused only minor changes in FEV1. In contrast, inhalation of 100 micrograms of PAF caused a significant fall in V30 from 2.64 +/- 0.35 to 1.35 +/- 0.43 l.min-1 (p < 0.05). Two days after PAF inhalation a leftward shift of the concentration-response curve to MCh was observed. The MCh concentration causing a 20% fall in FEV1 (PC20FEV1) was 11.25 +/- 1.78 and 2.38 +/- 1.29 mg.ml-1 (geometric mean +/- GSEM; p < 0.05) before and after PAF inhalation, respectively. PAF did not affect the maximal airway response to MCh. The maximum percentage fall in FEV1 was 36.2 +/- 1.9% at baseline and 37.6 +/- 1.8% after PAF inhalation. Likewise, maximum percentage change in V30 was 72.8 +/- 3.7% at baseline and 73.6 +/- 3.4% after PAF inhalation. The results of this study show that PAF inhalation increases airway sensitivity without altering the maximal bronchoconstrictive response to MCh in normal subjects.

Authors+Show Affiliations

Servizio di Fisiopathologia Respiratoria, G. Di Maria, Ospedale Ascoli-Tomaselli, Catania, Italy.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

8000412

Citation

Bellofiore, S, et al. "Inhaled Platelet-activating Factor Increases Airway Sensitivity but Not Maximal Airway Narrowing to Methacholine in Normal Subjects." Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace, vol. 49, no. 4, 1994, pp. 288-92.
Bellofiore S, Ciancio N, Pennisi A, et al. Inhaled platelet-activating factor increases airway sensitivity but not maximal airway narrowing to methacholine in normal subjects. Monaldi Arch Chest Dis. 1994;49(4):288-92.
Bellofiore, S., Ciancio, N., Pennisi, A., Coco, G., Passanisi, G., Ricciardolo, F. L., Novo, S., & Di Maria, G. U. (1994). Inhaled platelet-activating factor increases airway sensitivity but not maximal airway narrowing to methacholine in normal subjects. Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace, 49(4), 288-92.
Bellofiore S, et al. Inhaled Platelet-activating Factor Increases Airway Sensitivity but Not Maximal Airway Narrowing to Methacholine in Normal Subjects. Monaldi Arch Chest Dis. 1994;49(4):288-92. PubMed PMID: 8000412.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Inhaled platelet-activating factor increases airway sensitivity but not maximal airway narrowing to methacholine in normal subjects. AU - Bellofiore,S, AU - Ciancio,N, AU - Pennisi,A, AU - Coco,G, AU - Passanisi,G, AU - Ricciardolo,F L, AU - Novo,S, AU - Di Maria,G U, PY - 1994/9/1/pubmed PY - 1994/9/1/medline PY - 1994/9/1/entrez SP - 288 EP - 92 JF - Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace JO - Monaldi Arch Chest Dis VL - 49 IS - 4 N2 - To examine the effect of inhaled platelet-activating factor (PAF) on airway sensitivity and on maximal airway narrowing, we measured airway response to doubling concentrations of methacholine (MCh) 48 h before and 48 h after inhalation of 10, 50 and 100 micrograms of PAF in six nonatopic, nonasthmatic subjects. The forced expiratory volume in one second (FEV1) and airflow at 30 percent of vital capacity (V30) from partial forced expiration were used to assess changes in airway calibre. Inhalation of PAF caused only minor changes in FEV1. In contrast, inhalation of 100 micrograms of PAF caused a significant fall in V30 from 2.64 +/- 0.35 to 1.35 +/- 0.43 l.min-1 (p < 0.05). Two days after PAF inhalation a leftward shift of the concentration-response curve to MCh was observed. The MCh concentration causing a 20% fall in FEV1 (PC20FEV1) was 11.25 +/- 1.78 and 2.38 +/- 1.29 mg.ml-1 (geometric mean +/- GSEM; p < 0.05) before and after PAF inhalation, respectively. PAF did not affect the maximal airway response to MCh. The maximum percentage fall in FEV1 was 36.2 +/- 1.9% at baseline and 37.6 +/- 1.8% after PAF inhalation. Likewise, maximum percentage change in V30 was 72.8 +/- 3.7% at baseline and 73.6 +/- 3.4% after PAF inhalation. The results of this study show that PAF inhalation increases airway sensitivity without altering the maximal bronchoconstrictive response to MCh in normal subjects. SN - 1122-0643 UR - https://www.unboundmedicine.com/medline/citation/8000412/Inhaled_platelet_activating_factor_increases_airway_sensitivity_but_not_maximal_airway_narrowing_to_methacholine_in_normal_subjects_ DB - PRIME DP - Unbound Medicine ER -